|
UTP14C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.69040345557414E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.36428670980149E-13 |
| Normal-vs-Stage2 |
1.175910E-04 |
| Normal-vs-Stage3 |
1.641280E-04 |
| Normal-vs-Stage4 |
8.78809999993457E-07 |
| Stage1-vs-Stage2 |
6.901400E-01 |
| Stage1-vs-Stage3 |
7.069600E-01 |
| Stage1-vs-Stage4 |
6.910000E-01 |
| Stage2-vs-Stage3 |
9.659000E-01 |
| Stage2-vs-Stage4 |
5.123200E-01 |
| Stage3-vs-Stage4 |
6.023400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.05278025081179E-12 |
| Normal-vs-AfricanAmerican |
3.29720029057512E-10 |
| Normal-vs-Asian |
2.11819999984542E-07 |
| Caucasian-vs-AfricanAmerican |
6.045800E-01 |
| Caucasian-vs-Asian |
2.595200E-01 |
| AfricanAmerican-vs-Asian |
3.135200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67921232474555E-12 |
| Normal-vs-Female |
1.53300999999884E-05 |
| Male-vs-Female |
1.255670E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.79970000013796E-08 |
| Normal-vs-Extreme_Weight |
1.66422431391311E-12 |
| Normal-vs-Obese |
8.9011997772559E-10 |
| Normal-vs-Extreme_Obese |
8.563700E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.480000E-01 |
| Normal_Weight-vs-Obese |
5.710200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.236400E-01 |
| Extreme_Weight-vs-Obese |
7.980300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.225800E-01 |
| Obese-vs-Extreme_Obese |
8.150000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.37960009872052E-10 |
| Normal-vs-Age(41-60Yrs) |
2.14569995105052E-09 |
| Normal-vs-Age(61-80Yrs) |
2.75113265502114E-13 |
| Normal-vs-Age(81-100Yrs) |
1.60390001280319E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.653600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.775200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.723600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.772100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.206200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.199200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76625380987616E-12 |
| Normal-VS-Type2 PRCC |
1.21280000486834E-08 |
| Normal-VS-KIRP CIMP |
3.8205000274516E-09 |
| Normal-VS-Unclassified PRCC |
2.942200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.142000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.581000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.296100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.308100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.622800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.074230E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.26672064135892E-13 |
| Normal-vs-N1 |
2.435900E-03 |
| Normal-vs-N2 |
1.57826999999111E-05 |
| N0-vs-N1 |
1.566990E-01 |
| N0-vs-N2 |
4.650200E-01 |
| N1-vs-N2 |
2.959800E-01 |
|
|
